1. In the inclusion criteria, please state whether there were any minimum requirements for current drinking and depression. For example, was there a minimum threshold score on the BDI. Also indicate whether subjects with other comorbidity (personality disorder; psychotic disorders; other current substance use disorders) were excluded from the study or not.
2. Page 5 line 49 change Alcohol Dependency Disorder to alcohol dependence and Alcohol Abuse Disorder to alcohol abuse. Check conventions for capitalization of disorder names-usually these would not be capitalized.
3. For the randomization procedure, include information on whether randomization was with a computer-generated sequence, a random number table, or by some other method.
4. Although the protocol is already fixed, I suggest considering reporting on a measure of daily consumption (average daily consumption or average consumption per drinking day) as a secondary outcome measure. These data are presumably being collected with the timeline follow back anyway so there is no downside to including this as an outcome providing the reporting of the study focuses on the primary a priori outcome(s).
5. Please briefly mention missing data assumptions required for the intended multilevel modelling analysis, eg does the analysis required the assumption data are missing-at-random (MAR). 
REVIEWER

Michael
GENERAL COMMENTS
Hartnett and colleagues are planning to conduct a very interesting and important aftercare study on the effects of text messages (SMS) for patients with alcohol use disorder and a co-morbid depression. This is a very promising study and the future application of this approach could help this important group of dual diagnosis patients and help to ease the burden to their social environment.
There are a number of assessments at intake to the inpatient dual diagnosis program that might be of use for the evaluation e.g. as outcome predictors to the evaluation of the SMS aftercare intervention, there is no clear assessment at discharge followed by the randomization. Instead, the authors describe a recruitment during the 4-week inpatient program where the baseline assessment during an undefined time point takes place. Unfortunately, the study recruitment is already almost closed according to the manuscript. If the study would start now, I would strongly recommend postponing this baseline assessment as close to the inpatient discharge as possible and directly followed by the randomization. Ideally, during the same day, the discharge day. Many things can happen during the gap between the planned baseline assessment and the randomization as it is planned in the manuscript now (withdrawal and irregular discharge from the inpatient program, relapse etc.). Is there a possibility to count the days between the baseline assessment and the randomization post hoc? Another major comment: The inpatient program cited by the authors (Farren and Mc Elroy, 2008 ) also includes in its 3rd stage group sessions as aftercare up to 6 months. Are these groups still implemented during the SMS aftercare study or replaced by them? Please describe this in the Methods and Analysis -Study design and setting chapter. If they are still implemented, this should be mentioned in the discussion as a limitation confounding the effects of the SMS messages. Moreover, the four follow-up assessments will be contacted by a blinded researcher. Please also describe how these assessments will be performed (by telephone, face-to-face etc.) and if it is the same person who also conducts the follow-up blood testing.
Minor comments: -Although this is a single blind randomized controlled trial, I strongly recommend the authors to categorize their study as an aftercare study as the SMS messages are send after discharge and not already during the inpatient treatment. This should be mentioned also in the title and the abstract.
-Methods/Intervention protocol: The fortnightly phone calls to verify if the participants" mobile phones are still operational: please also write when this is planned to be done during the 6 months. If there is only one call, this could be done close to the 6 months follow-up assessment.
-Discontinuations: I strongly recommend trying to collect systematically and comparing the dropouts with those who continue the intervention. The latter should be described in the analysis section.
-Statistical analyses: Please mention also the statistical programs you plan to use. "For patients with Major Depressive Disorder a score of ≥ 14 on the Beck"s Depression Inventory (BDI) at baseline will be employed as an inclusion criteria, which indicates at least a mild depressive episode in the past two weeks. Patients with an established diagnosis of a comorbid personality disorder and/or anxiety disorder are eligible for inclusion, as are patients with a comorbid substance use disorder, provided that the primary substance use disorder is alcohol dependence. Comorbid disorders will be recorded and controlled for in the statistical analyses.
Patients will be excluded from the study if: (1) they do not consent to take part in the study; (2) they do not have a mobile phone or are unable to use SMS text messaging technology; (3) they would be unavailable for follow-up during the study period; (4) they have a psychotic disorder."
2 Page 5 line 49 change Alcohol Dependency Disorder to alcohol dependence and Alcohol Abuse Disorder to alcohol abuse. Check conventions for capitalization of disorder names-usually these would not be capitalized.
This correction has been made in the text where appropriate. The word "Alcohol Dependency Disorder" has been changed to "alcohol dependence" and "Alcohol Abuse Disorder" to "alcohol abuse". Capitalisation has also been modified.
3 For the randomization procedure, include information on whether randomization was with a computer-generated sequence, a random number table, or by some other method.
Information has now been provided on the randomisation procedure. The text reads as follows:
Simple random allocation using a random number generator will be conducted by the Research Director in order to ensure allocation concealment.
4 Although the protocol is already fixed, I suggest considering reporting on a measure of daily consumption (average daily consumption or average consumption per drinking day) as a secondary outcome measure. These data are presumably being collected with the timeline follow back anyway so there is no downside to including this as an outcome providing the reporting of the study focuses on the primary a priori outcome(s).
We thank the reviewer for this suggestion, however given that this study is a relapse prevention rather than a harm reduction intervention, daily alcohol consumption was not chosen as an outcome measure of interest. We wish instead to focus on abstinence success across the two groups, e.g. cumulative abstinence duration, proportion of patients still abstinent at the follow-up time points, time to first drink etc., rather than differences/reductions in daily alcohol consumption. For those patients not abstinent at follow-up, average consumption per drinking day could indeed be calculated from the timeline follow back, however at this point it is not intended to be a secondary measure.
5 Please briefly mention missing data assumptions required for the intended multilevel modelling analysis, eg does the analysis required the assumption data are missing-at-random (MAR).
The statistical analyses section has been amended to include the following additional data as follows:
This analysis will require the assumption that data are missing-at-random. That is, that that the probability of non-responding depends only on a participant"s observed characteristics.
# Reviewer 2 Comment Response
1 If the study would start now, I would strongly recommend postponing this baseline assessment as close to the inpatient discharge as possible and directly followed by the randomization.
We thank the reviewer for this suggestion. Although the study is currently underway and the baseline assessment cannot be entirely postponed, we wish to note that we have accounted for this consideration. The Beck Depression Inventory is administered both at the initial baseline assessment and immediately prior to the inpatient discharge to ensure that an accurate pre-discharge score is obtained. Thus, any variations in subjective mood ratings, which may be attributed to inpatient treatment, are assessed.
This has now been included in the text as follows:
The BDI-II will be re-administered immediately prior to inpatient discharge to account for subjective changes in depressive symptoms subsequent to completing the inpatient dual diagnosis programme.
2 The inpatient program cited by the authors (Farren and Mc Elroy, 2008 ) also includes in its 3rd stage group sessions as aftercare up to 6 months. Are these groups still implemented during the SMS aftercare study or replaced by them? Please describe this in the Methods and Analysis -Study design and setting chapter. If they are still implemented, this should be mentioned in the discussion as a limitation confounding the effects of the SMS messages.
The aftercare groups are still implemented, they are not replaced by the text messages. All patients who attend the inpatient programmes in the hospital are offered aftercare as part of their recovery programme, however not all patients choose to attend. At each follow-up time point in the study it will be recorded whether the patients in each group are attending aftercare, and in this way any potential group differences associated with aftercare attendance can be accounted for. In a previous study by our group (Agyapong et al., 2012) there were equal number of patients in the text message and control groups attending aftercare (intervention: 37.5%, control: 38.5%, p = 1.00), thus any group differences in outcomes were unlikely to be related to attendance of these sessions. Please see that the Methods section has been updated to include this point. It will also be discussed as a possible confounding factor in subsequent papers reporting on the study.
In the methods section it is stated:
"An outpatient aftercare programme is also offered to all patients. For the first three months patients attend a support group facilitated by an addiction counsellor once a week for half a day. Following this they attend a support group one evening per week for up to a year. At each followup assessment it will be recorded whether the patients in each group are attending aftercare, and in this way any potential group differences associated with aftercare attendance can be accounted for. In a previous study by our group 14 there were equal number of patients in the text message and control groups attending aftercare (intervention: 37.5%, control: 38.5%, p = 1.00), thus any group differences in outcomes were unlikely to be related to attendance of these sessions."
3 Moreover, the four follow-up assessments will be contacted by a blinded researcher. Please also describe how these assessments will be performed (by telephone, face-to-face etc.) and if it is the same person who also conducts the follow-up blood testing.
Information regarding how the follow-up assessments will be performed has now been included. The text now states:
"Participants will, at 3-, 6-, 9-, and 12-month follow-up intervals be contacted by a blinded researcher and invited to complete a face-to-face assessment involving the administration of the BDI…" With regard to follow-up blood testing. The text now states:
"Follow-up blood tests including MCV, AST and GGT will also be conducted by an independent phlebotomist."
